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Abstract 
Invasion of tumor cells is the primary cause of therapeutic failure in the treatment 
of malignant chondrosarcomas. Glial cell-derived neurotrophic factor (GDNF) 
plays a crucial role in migration and metastasis of human cancer cells. Integrins are 
the major adhesive molecules in mammalian cells. Here we found that GDNF 
directed the migration and increased cell surface expression of alphav and beta3 
integrin in human chondrosarcoma cells. Pretreated of JJ012 cells with MAPK 
kinase (MEK) inhibitors PD98059 or U0126 inhibited the GDNF-mediated 
migration and integrin expression. Stimulation of cells with GDNF increased the 
phosphorylation of MEK and extracellular signal-regulating kinase (ERK). In 
addition, NF-kappaB inhibitor (PDTC) or IkappaB protease inhibitor (TPCK) also 
inhibited GDNF-mediated cells migration and integrin up-regulation. Stimulation 
of cells with GDNF induced IkappaB kinase (IKKalpha/beta) phosphorylation, 
IkappaB phosphorylation, p65 Ser(536) phosphorylation, and kappaB-luciferase 
activity. Furthermore, the GDNF-mediated increasing of kappaB-luciferase activity 
was inhibited by PD98059, U0126, PDTC and TPCK or MEK, ERK, IKKalpha, 
and IKKbeta mutants. Taken together, these results suggest that the GDNF acts 
through MEK/ERK, which in turn activates IKKalpha/beta and NF-kappaB, 
resulting in the activations of alphavbeta3 integrin and contributing the migration 
of human chondrosarcoma cells. 
 
